March 11, 2013
In the following video, Motley Fool health care bureau chief Brenton Flynn discusses a recent Bloomberg article, which highlights the incredible benefits pharmaceutical companies enjoy through tax management strategies. Brenton tells investors who is profiting and by how much, and why other large-cap health care companies like UnitedHealth Group (NYSE: UNH ) and Express Scripts (NASDAQ: ESRX ) are missing out.
One of the biggest beneficiaries of a tax management strategy last year was Abbott Labs. For some Abbott Labs shareholders, the new year brought with it a new company called AbbVie. Formerly Abbott's branded pharmaceuticals business, shares of the new stock were distributed to investors on Jan. 2. To help investors better understand the situation, The Fool has created a brand new premium report on both stocks. Inside, we outline all of the must-know opportunities and risks facing both companies, so make sure to claim this report by clicking here now.